From: Detection of bladder cancer using urinary cell-free DNA and cellular DNA
Supernatant | Cancer (n = 92) | Control (n = 33) | PPV (%) | NPV (%) | ||
---|---|---|---|---|---|---|
n | Sensitivity (%) | n | Specificity (%) | |||
TERT | 42 | 46 | 0 | 100 | 100 | 40 |
FGFR3 | 35 | 38 | 0 | 100 | 100 | 37 |
TP53 | 27 | 29 | 0 | 100 | 100 | 34 |
PIK3CA | 24 | 26 | 0 | 100 | 100 | 33 |
KRAS | 15 | 16 | 0 | 100 | 100 | 30 |
CDKN2A | 9 | 10 | 0 | 100 | 100 | 28 |
HRAS | 9 | 10 | 0 | 100 | 100 | 28 |
AKT1 | 7 | 8 | 0 | 100 | 100 | 28 |
ERBB2 | 6 | 7 | 0 | 100 | 100 | 28 |
ACTB | 4 | 4 | 1 | 97 | 80 | 27 |
BRAF | 3 | 3 | 1 | 97 | 75 | 26 |
KDM6A | 3 | 3 | 1 | 97 | 75 | 26 |
EGFR | 2 | 2 | 0 | 100 | 100 | 27 |
CTNNB1 | 1 | 1 | 2 | 94 | 33 | 25 |
CUL1 | 1 | 1 | 0 | 100 | 100 | 27 |
FBXW7 | 1 | 1 | 0 | 100 | 100 | 27 |
PTEN | 1 | 1 | 0 | 100 | 100 | 27 |
STAG2 | 1 | 1 | 0 | 100 | 100 | 27 |
U2AF1 | 1 | 1 | 1 | 97 | 50 | 26 |
Sediment | Cancer (n = 92) | Control (n = 33) | PPV (%) | NPV (%) | ||
---|---|---|---|---|---|---|
n | Sensitivity (%) | n | Specificity (%) | |||
TERT | 44 | 48 | 0 | 100 | 100 | 41 |
FGFR3 | 34 | 37 | 1 | 97 | 97 | 36 |
PIK3CA | 22 | 24 | 1 | 97 | 96 | 31 |
TP53 | 20 | 22 | 6 | 82 | 77 | 27 |
KRAS | 14 | 15 | 0 | 100 | 100 | 30 |
HRAS | 13 | 14 | 0 | 100 | 100 | 29 |
CDKN2A | 9 | 10 | 0 | 100 | 100 | 28 |
AKT1 | 7 | 8 | 0 | 100 | 100 | 28 |
ERBB2 | 6 | 7 | 0 | 100 | 100 | 28 |
BRAF | 3 | 3 | 0 | 100 | 100 | 27 |
KDM6A | 2 | 2 | 0 | 100 | 100 | 27 |
CTNNB1 | 1 | 1 | 0 | 100 | 100 | 27 |
FBXW7 | 1 | 1 | 0 | 100 | 100 | 27 |
PTEN | 1 | 1 | 0 | 100 | 100 | 27 |
STAG2 | 1 | 1 | 0 | 100 | 100 | 27 |